International Journal of Medical Toxicology and Forensic Medicine

[1] Zheng J, Zhang G, Ren L. Advances in miRNA research: unraveling the complexities of gene regulation. Animal Model Exp Med. 2025;8(10):1741–59. [DOI: 10.1002/ame2.70076]

[2] Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105. [DOI: 10.1101/gr.082701.108]

[3] Nalbant E, Akkaya-Ulum YZ. Exploring regulatory mechanisms on miRNAs and their implications in inflammation-related diseases. Clin Exp Med. 2024;24(1):142. [DOI: 10.1007/s10238-024-01334-y]

[4] GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60. [DOI: 10.1016/S0140-6736(21)01169-7]

[5] Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011;8(2):613–28. [DOI: 10.3390/ijerph8020613]

[6] Ianosi ES, Tomoroga DM, Văsieșiu AM, Grigorescu BL, Vultur M, Ianosi MB. Epigenetic alterations induced by smoking and their intersection with artificial intelligence: a narrative review. Int J Environ Res Public Health. 2025;22(11):1622. [DOI: 10.3390/ijerph22111622]

[7] Momi N, Kaur S, Rachagani S, Ganti AK, Batra SK. Smoking and microRNA dysregulation: a cancerous combination. Trends Mol Med. 2014;20(1):36–47. [DOI: 10.1016/j.molmed.2013.10.005]

[8] Izzotti A, Larghero P, Longobardi M, Cartiglia C, Camoirano A, Steele VE, et al. Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat Res. 2011;717(1–2):9–16. [DOI: 10.1016/j.mrfmmm.2010.12.008]

[9] Sewer A, Zanetti F, Iskandar AR, Guedj E, Dulize R, Peric D, et al. A meta-analysis of microRNAs expressed in human aerodigestive epithelial cultures and their role as potential biomarkers of exposure response to nicotine-containing products. Toxicol Rep. 2020;7:1282–95. [DOI: 10.1016/j.toxrep.2020.09.001]

[10] Karabegović I, Maas SCE, Shuai Y, Ikram MA, Stricker B, Aerts J, et al. Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study. Hum Genomics. 2023;17(1):61. [DOI: 10.1186/s40246-023-00504-5]

[11] Mirra D, Esposito R, Spaziano G, Rafaniello C, Panico F, Squillante A, et al. miRNA signatures in alveolar macrophages related to cigarette smoke: assessment and bioinformatics analysis. Int J Mol Sci. 2025;26(3):1277. [DOI: 10.3390/ijms26031277]

[12] Korde A, Ramaswamy A, Anderson S, Jin L, Zhang JG, Hu B, et al. Cigarette smoke induces angiogenic activation in the cancer field through dysregulation of an endothelial microRNA. Commun Biol. 2025;8(1):511. [DOI: 10.1038/s42003-025-07710-y]

[13] Mishra AK, Mumtaz N, Misra MK. Identification of candidate mRNA genes and their potential microRNA targets in lung cancer induced by smoking tobacco. Front Biosci (Schol Ed). 2023;15(4):13. [DOI: 10.31083/j.fbs1504013]

[14] Hajiasgharzadeh K, Shahabi P, Karimi-Sales E, Alipour MR. Effects of nicotine on microRNA-124 expression in bile duct ligation-induced liver fibrosis in rats. BMC Pharmacol Toxicol. 2024;25(1):27. [DOI: 10.1186/s40360-024-00749-3]

[15] Hajsadeghi S, Iranpour A, Mirshafiee S, Nekouian R, Mollababaei M, Motevalli H, et al. Impact of smoking on microRNAs in significant coronary artery disease. Rom J Intern Med. 2025;63(1):49–59. [DOI: 10.2478/rjim-2024-0031]

[16] Ng TK, Carballosa CM, Pelaez D, Wong HK, Choy KW, Pang CP, et al. Nicotine alters microRNA expression and hinders human adult stem cell regenerative potential. Stem Cells Dev. 2013;22(5):781–90. [DOI: 10.1089/scd.2012.0434]

[17] Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–22. [DOI: 10.1038/nrd.2016.246]

[18] Steiling K, Ryan J, Brody JS, Spira A. The field of tissue injury in the lung and airway. Cancer Prev Res (Phila). 2008;1(6):396–403. [DOI: 10.1158/1940-6207.CAPR-08-0174]

[19] Vucic EA, Thu KL, Pikor LA, Enfield KS, Yee J, English JC, et al. Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology. BMC Cancer. 2014;14:778. [DOI: 10.1186/1471-2407-14-778]

[20] Mirra D, Esposito R, Spaziano G, Sportiello L, Panico F, Squillante A, et al. MicroRNA monitoring in human alveolar macrophages from patients with smoking-related lung diseases: a preliminary study. Biomedicines. 2024;12(5):1050. [DOI: 10.3390/biomedicines12051050]

[21] Ebrahimpour A, Shrestha S, Bonnen MD, Eissa NT, Raghu G, Ghebre YT. Nicotine modulates growth factors and microRNA to promote inflammatory and fibrotic processes. J Pharmacol Exp Ther. 2019;368(2):169–78. [DOI: 10.1124/jpet.118.252650]

[22] Paul S, Ruiz-Manriquez LM, Ambriz-Gonzalez H, Medina-Gomez D, Valenzuela-Coronado E, Moreno-Gomez P, et al. Impact of smoking-induced dysregulated human miRNAs in chronic disease development and their potential use in prognostic and therapeutic purposes. J Biochem Mol Toxicol. 2022;36(9):e23134. [DOI: 10.1002/jbt.23134]

[23] Li Y, Kowdley KV. MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics. 2012;10(5):246–53. [DOI: 10.1016/j.gpb.2012.07.005]

[24] Besaratinia A, Tommasi S. The untapped biomarker potential of microRNAs for health risk–benefit analysis of vaping vs. smoking. Cells. 2024;13(16):1330. [DOI: 10.3390/cells13161330]

[25] Roy B, Dunbar M, Agrawal J, Allen L, Dwivedi Y. Amygdala-based altered miRNome and epigenetic contribution of miR-128-3p in conferring susceptibility to depression-like behavior via Wnt signaling. Int J Neuropsychopharmacol. 2020;23(3):165–77. [DOI: 10.1093/ijnp/pyz071]

[26] Pittenger ST, Schaal VL, Moore D, Guda RS, Koul S, Yelamanchili SV, et al.. MicroRNA cluster miR199a/214 are differentially expressed in female and male rats following nicotine self-administration. Sci Rep. 2018;8(1):17464. [DOI: 10.1038/s41598-018-35747-z]

[27] Huang W, Li MD. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry. 2009;65(8):702–5. [DOI: 10.1016/j.biopsych.2008.11.024]

[28] Hu Z, Gao S, Lindberg D, Panja D, Wakabayashi Y, Li K, et al. Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia. Transl Psychiatry. 2019;9:196. [DOI: 10.1038/s41398-019-0538-y]

[29] Zhang Q, Tang S, Huang G, Liu H. Cigarettes, a skin killer! Cigarette smoke may cause ferroptosis in female skin. J Cosmet Dermatol. 2022;21(7):3085–94. [DOI: 10.1111/jocd.14559]

[30] Xiuli Y, Honglin W. miRNAs flowing up and down: the concerto of psoriasis. Front Med (Lausanne). 2021;8:646796. [DOI: 10.3389/fmed.2021.646796]

[31] Qin Z, Wang PY, Wan JJ, Zhang Y, Wei J, Sun Y, et al. MicroRNA124-IL6R mediates the effect of nicotine in inflammatory bowel disease by shifting Th1/Th2 balance toward Th1. Front Immunol. 2020;11:235. [DOI: 10.3389/fimmu.2020.00235]

[32] Qin Z, Wan JJ, Sun Y, Wu T, Wang PY, Du P, et al. Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3. J Mol Med (Berl). 2017;95(2):221–33. [DOI: 10.1007/s00109-016-1473-5]

[33] Caparrós E, García-Martinez I, Pedro Zapater, Lucía Madero, Valverde ÁM, Ana Gutiérrez, et al. An altered expression of miR-376a-3p and miR-20a-5p in peripheral blood exosomes regulates the autophagy and inflammatory systemic substrates, and relates to the smoking habit and age in Crohn’s disease. FASEB J. 2024;38(2):e23418. [DOI: 10.1096/fj.202301761R]

[34] Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, Wong CY, et al. NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis. 2011;32(2):240–5. [DOI: 10.1093/carcin/bgq240]

[35] Hardin LT, Abid N, Vang D, Han X, Thor D, Ojcius DM, et al. miRNAs mediate the impact of smoking on dental pulp stem cells via the p53 pathway. Toxicol Sci. 2024;200(1):47–56. [DOI: 10.1093/toxsci/kfae042]

[36] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. [DOI: 10.3322/caac.21590]

[37] Soleimani A, Farshchi HK, Mirzavi F, Zamani P, Ghaderi A, Amini Y, et al. The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma. Biochimie. 2020;176:21–30. [DOI: 10.1016/j.biochi.2020.06.001]

[38] Musri MM, Coll-Bonfill N, Maron BA, Peinado VI, Wang RS, Altirriba J, et al. MicroRNA dysregulation in pulmonary arteries from chronic obstructive pulmonary disease: relationships with vascular remodeling. Am J Respir Cell Mol Biol. 2018;59(4):490–9. [DOI: 10.1165/rcmb.2017-0040OC]

[39] King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949–61. [DOI: 10.1016/S0140-6736(11)60052-4]

[40] Samiei F, Jamshidzadeh A, Noorafshan A, Ghaderi A. Human placental extract ameliorates structural lung changes induced by amiodarone in rats. Iran J Pharm Res. 2016;15(Suppl):75–82.

[41] Zarei F, Simani M, Rajabi Moghaddam H, Ghaderi A. A review of cardiovascular diseases in substance use disorders: current knowledge and future perspectives. Addict Health. 2025;17:1722. [DOI: 10.34172/ahj.1722]

[42] Tamtaji OR, Milajerdi A, Reiner Ž, Asemi Z, Dadgostar E, Heidari-Soureshjani R, et al. A systematic review and meta-analysis: the effects of probiotic supplementation on metabolic profile in patients with neurological disorders. Complement Ther Med. 2020;53:102507. [DOI: 10.1016/j.ctim.2020.102507]

[43] Francis HO, Chinezie J, Awoleye MO, Agbonifo WO, Adedeji TG. Exploring the effects of vitamin D supplementation on cognitive functions and mental health status in subjects under methadone maintenance treatment. J Addict Med. 2020;14(1):18–25. [DOI: 10.1097/ADM.0000000000000550]

[44] Molavi N, Rasouli-Azad M, Mirzaei H, Matini AH, Banafshe HR, Valiollahzadeh M, et al. The effects of probiotic supplementation on opioid-related disorder in patients under methadone maintenance treatment programs. Int J Clin Pract. 2022;2022:1206914. [DOI: 10.1155/2022/1206914]

[45] Sadeghi-Gandomani HR, Banafshe HR, Sadat Z, Ghaderi A, Shirvanizadeh F, Afshar M, et al. The effects of crocin supplementation on sleep quality, general health, and happiness in elderly population: a randomized, double-blind, placebo-controlled trial. Int J Med Toxicol Forensic Med. 2023;13(1):38718. [DOI: 10.32598/ijmtfm.v12i4.38718]

[46] Mahdavi M, Ghoreishi FS, Ketabi M, Simani M, Ghaderi A, et al. Adjunctive nano-curcumin for methamphetamine-induced psychosis: a randomized, double-blind, placebo-controlled trial on craving, psychotic symptoms, and inflammatory pathways. Jundishapur J Nat Pharm Prod. 2026;21(2):e170012. [DOI: 10.5812/jjnpp-170012]

[47] Esfahanian F, Fallah M, Vahed N, Masoumzadeh S, Ghaderi A, Asadollahi Shahir AA. A systematic review of dermatologic manifestations of illicit substance use: converging vascular, immune, and behavioral pathways. Int J Med Toxicol Forensic Med. 2026;16:1–14. [DOI: 10.22037/ijmtfm.v16.51860]

[48] Francis HO, Chinezie J, Awoleye MO, Agbonifo WO, Adedeji TG. Mechanisms of liver dysfunction induced by high-fat diet and cigarette smoke: a systematic review of post-transcriptional and post-translational modifications. J Biom Innov Tech. 2025;1(2):248–63. [Link]

[49] Banerjee A, Luettich K. MicroRNAs as potential biomarkers of smoking-related diseases. Biomark Med. 2012;6(5):671–84. [DOI: 10.2217/bmm.12.50]

[50] Zeng Z, Liu X, Xiang F, He X, Li J, Liu H, et al. MicroRNA-21 plays a role in exacerbating chronic obstructive pulmonary disease by regulating necroptosis and apoptosis in bronchial epithelial cells. Tob Induc Dis. 2025;23:202182. [DOI: 10.18332/tid/202182]

[51] Chakraborty C, Sharma AR, Sharma G, Lee SS. Therapeutic advances of miRNAs: a preclinical and clinical update. J Adv Res. 2020;28:127–38. [DOI: 10.1016/j.jare.2020.08.012]

[52] Andersson BÅ, Sayardoust S, Löfgren S, Rutqvist LE, Laytragoon-Lewin N. Cigarette smoking affects microRNAs and inflammatory biomarkers in healthy individuals and an association to single nucleotide polymorphisms is indicated. Biomarkers. 2019;24(2):180–5. [DOI: 10.1080/1354750X.2018.1539772]

[53] Willinger CM, Rong J, Tanriverdi K, Courchesne P, Huan T, Wasserman GA, et al. MicroRNA signature of cigarette smoking and evidence for a putative causal role of microRNAs in smoking-related inflammation and target organ damage. Circ Cardiovasc Genet. 2017;10(5):e001678. [DOI: 10.1161/CIRCGENETICS.116.001678]

[54] Yokoyama Y, Mise N, Suzuki Y, Tada-Oikawa S, Izuoka K, Zhang L, et al. MicroRNAs as potential mediators for cigarette smoking induced atherosclerosis. Int J Mol Sci. 2018;19(4):1097. [DOI: 10.3390/ijms19041097]

[55] Zeng Z, He S, Lu J, Liu C, Lin L, Xie L, et al. MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy. Exp Lung Res. 2018;44(2):89–97. [DOI: 10.1080/01902148.2018.1439548]

[56] Babu N, Advani J, Solanki HS, Patel K, Jain A, Khan AA, et al. miRNA and proteomic dysregulation in non-small cell lung cancer in response to cigarette smoke. Microrna. 2018;7(1):38–53. [DOI: 10.2174/2211536607666180103165343]

[57] Khan AA, Advani J, Patel K, Nanjappa V, Datta KK, Solanki HS, et al. Chronic exposure to cigarette smoke and chewing tobacco alters expression of microRNAs in esophageal epithelial cells. Microrna. 2018;7(1):28–37. [DOI: 10.2174/2211536607666171213123907]

[58] Gu W, Yuan Y, Yang H, Wu H, Wang L, Tang Z, et al. Role of miR-195 in cigarette smoke-induced chronic obstructive pulmonary disease. Int Immunopharmacol. 2018;55:49–54. [DOI: 10.1016/j.intimp.2017.11.030]

[59] Shen W, Liu J, Fan M, Wang S, Zhang Y, Wen L, et al. miR-3202 protects smokers from chronic obstructive pulmonary disease through inhibiting FAIM2: an in vivo and in vitro study. Exp Cell Res. 2018;362(2):370–7. [DOI: 10.1016/j.yexcr.2017.11.038]

[60] Xue H, Li MX. MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53: microRNA-150 in CS-induced lung inflammation. Hum Exp Toxicol. 2018;37(9):920–8. [DOI: 10.1177/0960327117741749]

[61] Xu H, Sun Q, Lu L, Luo F, Zhou L, Liu J, et al. MicroRNA-218 acts by repressing TNFR1-mediated activation of NF-κB, which is involved in MUC5AC hyper-production and inflammation in smoking-induced bronchiolitis of COPD. Toxicol Lett. 2017;280:171–80. [DOI: 10.1016/j.toxlet.2017.08.079]

[62] Conickx G, Avila Cobos F, van den Berge M, Faiz A, Timens W, Hiemstra PS, et al. MicroRNA profiling in lung tissue and bronchoalveolar lavage of cigarette smoke-exposed mice and in COPD patients: a translational approach. Sci Rep. 2017;7(1):12871. [DOI: 10.1038/s41598-017-13265-8]

[63] Krishnan AR, Zheng H, Kwok JG, Qu Y, Zou AE, Korrapati A, et al. A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma. Oral Oncol. 2017;72:56–64. [DOI: 10.1016/j.oraloncology.2017.07.009]

[64] Du Y, Ding Y, Chen X, Mei Z, Ding H, Wu Y, et al. MicroRNA-181c inhibits cigarette smoke-induced chronic obstructive pulmonary disease by regulating CCN1 expression. Respir Res. 2017;18(1):155. [DOI: 10.1186/s12931-017-0639-1]

[65] Advani J, Subbannayya Y, Patel K, Khan AA, Patil AH, Jain AP, et al. Long-term cigarette smoke exposure and changes in miRNA expression and proteome in non-small-cell lung cancer. OMICS. 2017;21(7):390–403. [DOI: 10.1089/omi.2017.0045]

[66] Osei ET, Florez-Sampedro L, Tasena H, Faiz A, Noordhoek JA, Timens W, et al. miR-146a-5p plays an essential role in the aberrant epithelial-fibroblast cross-talk in COPD. Eur Respir J. 2017;49(5):1602538. [DOI: 10.1183/13993003.02538-2016]

[67] Dhahri W, Dussault S, Haddad P, Turgeon J, Tremblay S, Rolland K, et al. Reduced expression of let-7f activates TGF-β/ALK5 pathway and leads to impaired ischaemia-induced neovascularization after cigarette smoke exposure. J Cell Mol Med. 2017;21(9):2211–22. [DOI: 10.1111/jcmm.13144]

[68] Shen W, Liu J, Zhao G, Fan M, Song G, Zhang Y, et al. Repression of Toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:705–15. [DOI: 10.2147/COPD.S128031]

[69] Lu L, Qi H, Luo F, Xu H, Ling M, Qin Y, et al. Feedback circuitry via let-7c between lncRNA CCAT1 and c-Myc is involved in cigarette smoke extract-induced malignant transformation of HBE cells. Oncotarget. 2017;8(12):19285–97. [DOI: 10.18632/oncotarget.15195]

[70] Rogers S, de Souza AR, Zago M, Iu M, Guerrina N, Gomez A, et al. Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure. Sci Rep. 2017;7:40539. [DOI: 10.1038/srep40539]

[71] Sewer A, Kogel U, Talikka M, Wong ET, Martin F, Xiang Y, et al. Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke. Regul Toxicol Pharmacol. 2016;81 Suppl 2:S82–92. [DOI: 10.1016/j.yrtph.2016.11.018]

[72] Kato R, Mizuno S, Kadowaki M, Shiozaki K, Akai M, Nakagawa K, et al. Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease. Respir Res. 2016;17(1):139. [DOI: 10.1186/s12931-016-0452-2]

[73] Drummond CA, Crotty Alexander LE, Haller ST, Fan X, Xie JX, Kennedy DJ, et al. Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosis. Physiol Genomics. 2016;48(12):950–60. [DOI: 10.1152/physiolgenomics.00070.2016]

[74] Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I. Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21: an observational study in patients with coronary artery disease. Immunobiology. 2017;222(2):169–75. [DOI: 10.1016/j.imbio.2016.10.007]

[75] Mullany LE, Herrick JS, Wolff RK, Stevens JR, Slattery ML. Association of cigarette smoking and microRNA expression in rectal cancer: insight into tumor phenotype. Cancer Epidemiol. 2016;45:98–107. [DOI: 10.1016/j.canep.2016.10.011]

[76] Izzotti A, Balansky R, Ganchev G, Iltcheva M, Longobardi M, Pulliero A, et al. Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice. Oncotarget. 2016;7(51):84758–74. [DOI: 10.18632/oncotarget.12475]

[77] Lu L, Xu H, Luo F, Liu X, Lu X, Yang Q, et al. Epigenetic silencing of miR-218 by the lncRNA CCAT1, acting via BMI1, promotes an altered cell cycle transition in the malignant transformation of HBE cells induced by cigarette smoke extract. Toxicol Appl Pharmacol. 2016;304:30–41. [DOI: 10.1016/j.taap.2016.05.012]

[78] Wang J, Zhang C, Zhang Z, Zheng Z, Sun D, Yang Q, et al. A functional variant rs6435156C>T in BMPR2 is associated with increased risk of chronic obstructive pulmonary disease (COPD) in Southern Chinese population. EBioMedicine. 2016;5:167–74. [DOI: 10.1016/j.ebiom.2016.02.004]

[79] Shi B, Gao H, Zhang T, Cui Q. Analysis of plasma microRNA expression profiles revealed different cancer susceptibility in healthy young adult smokers and middle-aged smokers. Oncotarget. 2016;7(16):21676–85. [DOI: 10.18632/oncotarget.7866]

[80] Li W, Liu Z, Jia C, Yin B, Shu B. [Effects of microRNA-146a on Fas-associated factor 2 and inflammatory factors in human lung adenocarcinoma A549 cells under the stimulation of cigarette smoke extract]. Zhonghua Shao Shang Za Zhi. 2016;32(2):97–104. Chinese. [DOI: 10.3760/cma.j.issn.1009-2587.2016.02.008]

[81] Gong J, Chu Y, Xu M, Huo J, Lv L. Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p/COX-2 pathway. Oncol Rep. 2016;35(1):463–71. [DOI: 10.3892/or.2015.4379]

[82] Lu L, Luo F, Liu Y, Liu X, Shi L, Lu X, et al. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract. Toxicol Appl Pharmacol. 2015;289(2):276–85. [DOI: 10.1016/j.taap.2015.09.016]

[83] Xi S, Inchauste S, Guo H, Shan J, Xiao Z, Xu H, et al. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene. 2015;34(44):5548–59. [DOI: 10.1038/onc.2015.10]

[84] Huang J, Wu J, Li Y, Li X, Yang T, Yang Q, et al. Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer. Biomed Res Int. 2014;2014:364316. [DOI: 10.1155/2014/364316]

[85] Wang B, Liu Y, Luo F, Xu Y, Qin Y, Lu X, et al. Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract. Arch Toxicol. 2016;90(2):449–61. [DOI: 10.1007/s00204-014-1435-z]

[86] Wang M, Huang Y, Liang Z, Liu D, Lu Y, Dai Y, et al. Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease. Clin Respir J. 2016;10(1):104–11. [DOI: 10.1111/crj.12194]

[87] Kanamori C, Yasuda K, Sumi G, Kimura Y, Tsuzuki T, Cho H, et al. Effect of cigarette smoking on mRNA and protein levels of oxytocin receptor and on contractile sensitivity of uterine myometrium to oxytocin in pregnant women. Eur J Obstet Gynecol Reprod Biol. 2014;178:142–7. [DOI: 10.1016/j.ejogrb.2014.03.037]

[88] Zhang Y, Pan T, Zhong X, Cheng C. Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells. Tumour Biol. 2014;35(7):7063–72. [DOI: 10.1007/s13277-014-1968-z]

[89] Zago M, Rico de Souza A, Hecht E, Rousseau S, Hamid Q, Eidelman DH, et al. The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts. Toxicol Lett. 2014;226(2):107–16. [DOI: 10.1016/j.toxlet.2014.01.020]

[90] Zhao Y, Xu Y, Li Y, Xu W, Luo F, Wang B, et al. NF-κB-mediated inflammation leading to EMT via miR-200c is involved in cell transformation induced by cigarette smoke extract. Toxicol Sci. 2013;135(2):265–76. [DOI: 10.1093/toxsci/kft150]

[91] Takahashi K, Yokota S, Tatsumi N, Fukami T, Yokoi T, Nakajima M. Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol Appl Pharmacol. 2013;272(1):154–60. [DOI: 10.1016/j.taap.2013.05.018]

[92] Halappanavar S, Nikota J, Wu D, Williams A, Yauk CL, Stampfli M. IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation. J Immunol. 2013;190(7):3679–86. [DOI: 10.4049/jimmunol.1202456]

[93] Xi S, Xu H, Shan J, Tao Y, Hong JA, Inchauste S, et al. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. J Clin Invest. 2013;123(3):1241–61. [DOI: 10.1172/JCI61271]

[94] Pal A, Melling G, Hinsley EE, Kabir TD, Colley HE, Murdoch C, et al. Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145. J Oral Pathol Med. 2013;42(4):309–14. [DOI: 10.1111/jop.12017]

[95] Graff JW, Powers LS, Dickson AM, Kim J, Reisetter AC, Hassan IH, et al. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One. 2012;7(8):e44066. [DOI: 10.1371/journal.pone.0044066]

[96] Yuchuan H, Ya D, Jie Z, Jingqiu C, Yanrong L, Dongliang L, et al. Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis. Toxicol Ind Health. 2014;30(2):182–91. [DOI: 10.1177/0748233712452606]

[97] Huang Y, Dai Y, Zhang J, Wang C, Li D, Cheng J, et al. Circulating microRNAs as potential biomarkers for smoking-related interstitial fibrosis. Biomarkers. 2012;17(5):435–40. [DOI: 10.3109/1354750X.2012.680611]

[98] Marczylo EL, Amoako AA, Konje JC, Gant TW, Marczylo TH. Smoking induces differential miRNA expression in human spermatozoa: a potential transgenerational epigenetic concern? Epigenetics. 2012;7(5):432–9. [DOI: 10.4161/epi.19794]

[99] Izzotti A, Larghero P, Balansky R, Pfeffer U, Steele VE, De Flora S. Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung. Mutat Res. 2011;717(1–2):17–24. [DOI: 10.1016/j.mrfmmm.2010.10.003]

[100] Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, Marsit CJ. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics. 2010;5(7):583–9. [DOI: 10.4161/epi.5.7.12762]

[101] Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A. 2009;106(7):2319–24. [DOI: 10.1073/pnas.0806383106]

[102] Wang Z, Peng Y, Zhou H, Zhang M, Ju D, Chen Z. miRNA-based drugs: challenges and delivery strategies. Appl Microbiol Biotechnol. 2025;109(1):247. [DOI: 10.1007/s00253-025-13620-0]

[103] Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: a systematic review. Hepatol Res. 2016;46(5):391–406. [DOI: 10.1111/hepr.12606]

[104] Terrinoni A, Calabrese C, Basso D, Aita A, Caporali S, Plebani M, et al. The circulating miRNAs as diagnostic and prognostic markers. Clin Chem Lab Med. 2019;57(7):932–53. [DOI: 10.1515/cclm-2018-0838]

[105] Takada Y, Shibuta T, Hatano M, Sato K, Koga M, Ishibashi A, et al. Pre-analytical modification of serum miRNAs: diagnostic reliability of serum miRNAs in hemolytic diseases. J Clin Med. 2021;10(21):5045. [DOI: 10.3390/jcm10215045]